A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf
.
Alliance for Aging Research AD Biomarkers Work Group: structural MRI
2011
Neurobiology of Aging
Biomarkers of Alzheimer's disease (AD) are increasingly important. All modern AD therapeutic trials employ AD biomarkers in some capacity. In addition, AD biomarkers are an essential component of recently updated diagnostic criteria for AD from the National Institute on Aging -Alzheimer's Association. Biomarkers serve as proxies for specific pathophysiological features of disease. The 5 most well established AD biomarkers include both brain imaging and cerebrospinal fluid (CSF) measures -CSF
doi:10.1016/j.neurobiolaging.2011.09.011
pmid:22078173
pmcid:PMC3661287
fatcat:kyu6vx6a6rezlb4j6laq5emgte